Understanding Your BVD Symptom Quiz Results: What the Score Means

If you have taken the Binocular Vision Dysfunction (BVD) symptom quiz — either on our website or through another source — you may be wondering what your score actually means and whether it warrants further evaluation. This guide explains the quiz, how to interpret your results, and what the next steps look like.

The BVD symptom quiz is a validated screening questionnaire developed to identify patients who may have Binocular Vision Dysfunction — a subtle eye misalignment that produces a wide range of neurological symptoms. It was developed based on research into the symptom patterns most commonly associated with BVD and has been validated against clinical diagnosis.

The quiz asks about the frequency and severity of symptoms across several domains: headaches, dizziness, reading difficulty, anxiety, neck pain, and visual discomfort. Each symptom is scored based on how often it occurs and how much it affects daily life.

A score alone cannot diagnose BVD — only a NeuroVisual evaluation with a prism trial can confirm it. But the score tells you whether the evaluation is worth pursuing, and which symptoms to discuss with Dr. Payne.

A low score suggests that BVD is unlikely to be a significant contributor to your current symptoms. However, if you have specific symptoms that concern you — particularly headaches with reading, or dizziness in visually complex environments — it is still worth mentioning to your eye doctor during your next exam.

A moderate score indicates a meaningful symptom burden that is consistent with BVD. Many patients in this range have been managing their symptoms for years without a clear diagnosis. A NeuroVisual evaluation is recommended to determine whether BVD is contributing to your symptoms and whether prism lens therapy would help.

A high score indicates a significant symptom burden strongly consistent with BVD. Patients in this range often have multiple overlapping symptoms — headaches, dizziness, reading difficulty, anxiety, and neck pain — that have not responded adequately to conventional treatment. A NeuroVisual evaluation is strongly recommended.

While the total score provides a useful overall picture, certain symptom patterns are particularly suggestive of BVD:

High-specificity symptoms:

• Dizziness or disorientation in crowded or visually busy environments
• Headaches that are consistently worse after reading or screen use
• Difficulty reading — words moving, blurring, or losing place
• Head tilting to one side (visible in photos)
• Symptoms that improve with one eye closed

Supporting symptoms:

• Neck pain and shoulder tension
• Anxiety in visually complex environments
• Light sensitivity
• Difficulty with depth perception
• Fatigue disproportionate to visual tasks

The symptom quiz is a screening tool — it identifies patients who are likely to benefit from a NeuroVisual evaluation, but it cannot diagnose BVD or determine the appropriate prism prescription. Only a comprehensive clinical evaluation can do that.

The quiz also cannot distinguish between BVD and other conditions that produce similar symptoms — including vestibular disorders, migraine, cervicogenic headache, and anxiety disorders. The NeuroVisual evaluation is designed to make these distinctions.

At Trendsetter Eyewear, a NeuroVisual evaluation with Dr. Cynthia Payne includes:

1. Detailed symptom review — We go through your quiz responses and symptom history in detail
2. Standard vision testing — Visual acuity, refraction, and eye health assessment
3. Binocular vision testing — Cover testing, prism testing, and vergence assessment to measure eye alignment
4. Accommodative testing — Assessment of focusing ability at different distances
5. NeuroLens measurement (when indicated) — Specialized measurement of eye misalignment across the visual range
6. Trial prism assessment — In many cases, we can give you a sense of how prism correction feels before committing to new lenses

If BVD is confirmed, treatment typically involves:

• Micro-prism lenses incorporated into your eyeglass prescription
• NeuroLens for patients with significant near-vision symptoms and trigeminal involvement
• Vision therapy in some cases, to retrain the binocular vision system
• Follow-up evaluation at 4–6 weeks to assess response and fine-tune the prescription

Most patients notice meaningful improvement within the first week of wearing their prism lenses. The full benefit typically develops over 4–8 weeks as the visual system adapts to the correction.

If your quiz score was moderate or high — or if you recognize your symptoms in the descriptions above — a NeuroVisual evaluation is a logical next step. It is a non-invasive, comprehensive assessment that can provide answers after years of unexplained symptoms.

Call (702) 479-5222 or schedule your NeuroVisual evaluation at Trendsetter Eyewear in Summerlin, Las Vegas. You can also take the BVD symptom quiz if you have not already.

A high score (51+) indicates a significant symptom burden strongly consistent with Binocular Vision Dysfunction. Patients in this range often have multiple overlapping symptoms — headaches, dizziness, reading difficulty, anxiety, and neck pain — that have not responded adequately to conventional treatment. A NeuroVisual evaluation is strongly recommended.

No. The quiz is a screening tool — it identifies patients who are likely to benefit from a NeuroVisual evaluation, but it cannot diagnose BVD or determine the appropriate prism prescription. Only a comprehensive clinical evaluation with prism testing can confirm BVD and guide treatment.

The evaluation includes a detailed symptom review, standard vision testing, specialized binocular vision testing (cover testing, prism testing, vergence assessment), accommodative testing, and in many cases a NeuroLens measurement. Dr. Payne will explain what she finds and whether prism lens therapy is likely to help.

Many patients notice meaningful improvement within the first week of wearing their prism lenses. Headaches, dizziness, and reading difficulty often reduce significantly within days. Full benefit typically develops over 4–8 weeks as the visual system adapts to the correction.

A low score makes BVD less likely but does not rule it out. If you have specific symptoms that concern you — particularly headaches with reading, dizziness in visually complex environments, or difficulty concentrating on close work — mention them to Dr. Payne during your eye exam. The clinical evaluation is more definitive than the screening score alone.